You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,440,170


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,440,170 protect, and when does it expire?

Patent 8,440,170 protects SUPRENZA and is included in one NDA.

This patent has two patent family members in two countries.

Summary for Patent: 8,440,170
Title:Orally disintegrating tablets with speckled appearance
Abstract: Orally disintegrating tablets containing colored granules of a water-soluble sugar which give them a speckled appearance are described. The orally disintegrating tablets with speckled appearance are readily and easy identifiable by physicians, nurses and patients.
Inventor(s): Stroppolo; Federico (Mezzovico, CH), Ardalan; Shahbaz (Mezzovico, CH)
Assignee: Alpex Pharma SA (Mezzovico, CH)
Application Number:12/811,737
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,440,170
Patent Claim Types:
see list of patent claims
Composition; Formulation; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,440,170

Introduction

United States Patent 8,440,170, titled "Orally Disintegrating Tablets Containing Colored Granules of a Water-Soluble Sugar," is a patent that describes a specific formulation of orally disintegrating tablets. To understand the scope and claims of this patent, it is essential to delve into its details, the patent landscape, and the broader context of patent analysis.

Patent Overview

The patent, US-8440170-B2, was granted for orally disintegrating tablets that contain colored granules of a water-soluble sugar, giving them a speckled appearance. This innovation is significant in the pharmaceutical industry, particularly for patient compliance and aesthetic appeal[2].

Claims Analysis

Independent Claims

The independent claims of a patent are crucial as they define the broadest scope of the invention. For US-8440170-B2, the independent claims would typically outline the core components and processes involved in creating these orally disintegrating tablets.

  • Claim 1: This claim usually sets the foundation by describing the main elements of the invention, such as the composition of the tablets, the presence of colored granules, and the water-soluble sugar.
  • Claim Scope Metrics: Research suggests that the scope of patent claims can be measured using metrics such as independent claim length and independent claim count. Narrower claims, as indicated by shorter lengths and fewer counts, are often associated with a higher probability of grant and a shorter examination process[3].

Dependent Claims

Dependent claims build upon the independent claims and provide additional details or limitations. These claims help to further define the invention and can include specific embodiments or variations.

  • Dependent Claim Examples: These might include claims that specify the type of water-soluble sugar used, the method of incorporating colored granules, or the exact formulation ratios.

Patent Scope

Metrics for Measuring Scope

The scope of a patent is a critical aspect that determines its breadth and impact. Metrics such as independent claim length and count can provide insights into the patent's scope.

  • Independent Claim Length: Shorter independent claims generally indicate a narrower scope, which can be beneficial for clarity and enforceability[3].
  • Independent Claim Count: Fewer independent claims suggest a more focused invention, potentially reducing the complexity and breadth of the patent.

Examination Process Impact

The patent examination process often narrows the scope of patent claims. This is evident from studies showing that the examination process tends to reduce claim length and count, especially when the examination duration is longer[3].

Patent Landscape

Industry Context

The pharmaceutical industry is highly competitive, with numerous patents covering various aspects of drug formulation and delivery. The landscape for orally disintegrating tablets is particularly crowded, with several patents addressing different aspects such as taste masking, stability, and patient compliance.

  • Competing Patents: Other patents in this space might cover similar formulations or different approaches to creating orally disintegrating tablets. Analyzing these patents can help in understanding the competitive landscape and potential infringement risks.

Global Patent Landscape

To fully understand the scope of US-8440170-B2, it is essential to look beyond the U.S. patent system. International patent databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO) can offer insights into similar patents filed globally[1].

Patent Classification

Patent classification systems, such as the Cooperative Patent Classification (CPC) or the International Patent Classification (IPC), help in organizing patents into specific technology groupings. For US-8440170-B2, the classification would likely fall under categories related to pharmaceutical formulations and drug delivery systems.

  • Classification Benefits: Using classification systems can streamline the search process, ensuring that results are highly relevant and saving time in patent research[4].

Patent Assignment and Ownership

Understanding the current ownership and any changes in ownership of the patent is crucial for licensing, litigation, and other business decisions.

  • Patent Assignment Search: The USPTO provides tools for searching patent assignments and changes in ownership, which can be accessed through the Patent Assignment Search website[1].

Public Search and Analysis Tools

Several tools and resources are available for searching and analyzing patents, including:

  • Patent Public Search: This tool provides enhanced access to prior art and is a powerful resource for conducting comprehensive patent searches[1].
  • PatentsView: This platform offers visualization, data dissemination, and analysis of intellectual property data, which can be useful for creating patent landscape reports[4].

Forward and Backward Citations

Analyzing forward and backward citations can provide insights into the patent's impact and its place within the broader technological landscape.

  • Forward Citations: These indicate how often the patent has been cited by later patents, which can be a measure of its influence and relevance.
  • Backward Citations: These show the prior art cited by the patent, helping to understand the foundation upon which the invention was built.

Litigation and Challenges

Patents can be subject to various legal challenges, including reviews by the Patent Trial and Appeal Board (PTAB).

  • PTAB Reviews: If a patent is challenged, the PTAB may review the patent to determine its validity. This process can significantly impact the patent's scope and claims[5].

Key Takeaways

  • Patent Claims: The scope and claims of US-8440170-B2 are defined by its independent and dependent claims, with narrower claims often being more favorable.
  • Patent Scope Metrics: Metrics such as independent claim length and count are useful in measuring the patent's scope.
  • Patent Landscape: Understanding the global patent landscape and classification systems is crucial for navigating the competitive environment.
  • Public Search Tools: Utilizing tools like Patent Public Search and PatentsView can enhance the search and analysis process.
  • Ownership and Citations: Keeping track of ownership changes and analyzing citations can provide valuable insights into the patent's impact.

FAQs

Q: What is the main innovation described in US-8440170-B2? A: The main innovation is the creation of orally disintegrating tablets containing colored granules of a water-soluble sugar, giving them a speckled appearance.

Q: How can the scope of a patent be measured? A: The scope of a patent can be measured using metrics such as independent claim length and independent claim count.

Q: What is the significance of patent classification systems? A: Patent classification systems help in organizing patents into specific technology groupings, making it easier to search and find relevant patents.

Q: Where can I find information on patent assignments and changes in ownership? A: Information on patent assignments and changes in ownership can be found through the USPTO's Patent Assignment Search website.

Q: How can I analyze the impact of a patent? A: Analyzing forward and backward citations, as well as using tools like PatentsView, can provide insights into a patent's impact and its place within the technological landscape.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Unified Patents Portal - US-8440170-B2: https://portal.unifiedpatents.com/patents/patent/US-8440170-B2
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Brown University Library Guides - Patents: https://libguides.brown.edu/patent
  5. Law360 - Kyle Bass Convinces PTAB To Review Citius Drug Patent: https://www.law360.com/articles/799211/kyle-bass-convinces-ptab-to-review-citius-drug-patent

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,440,170

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Citius Pharms SUPRENZA phentermine hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 202088-001 Jun 13, 2011 DISCN No No 8,440,170 ⤷  Subscribe Y ⤷  Subscribe
Citius Pharms SUPRENZA phentermine hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 202088-002 Jun 13, 2011 DISCN No No 8,440,170 ⤷  Subscribe Y ⤷  Subscribe
Citius Pharms SUPRENZA phentermine hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 202088-003 Mar 27, 2012 DISCN No No 8,440,170 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,440,170

PCT Information
PCT FiledJanuary 30, 2009PCT Application Number:PCT/EP2009/051055
PCT Publication Date:August 13, 2009PCT Publication Number: WO2009/098169

International Family Members for US Patent 8,440,170

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2254558 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 2009098169 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.